Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Economic evaluations of hepatitis A vaccination in middle-income countries.

Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ.

Expert Rev Vaccines. 2013 Dec;12(12):1479-94. doi: 10.1586/14760584.2013.851008. Epub 2013 Oct 30. Review.

PMID:
24168129
[PubMed - indexed for MEDLINE]
2.

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.

Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.

Vaccine. 2012 Dec 14;30(52):7489-97. doi: 10.1016/j.vaccine.2012.10.056. Epub 2012 Oct 27.

PMID:
23107593
[PubMed - indexed for MEDLINE]
Free Article
3.

Regional variation in the cost effectiveness of childhood hepatitis A immunization.

Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.

Pediatr Infect Dis J. 2003 Oct;22(10):904-14.

PMID:
14551492
[PubMed - indexed for MEDLINE]
4.

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.

Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL.

Vaccine. 2005 Jul 14;23(32):4110-9. Epub 2005 Apr 12.

PMID:
15964479
[PubMed - indexed for MEDLINE]
5.

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.

Vaccine. 2004 May 7;22(15-16):1862-7.

PMID:
15121296
[PubMed - indexed for MEDLINE]
6.

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.

Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, John-Baptiste A, Woo G, Krahn M.

Pharmacoeconomics. 2008;26(1):17-32. Review.

PMID:
18088156
[PubMed - indexed for MEDLINE]
7.

Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.

Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL.

Rev Panam Salud Publica. 2007 Jun;21(6):345-56.

PMID:
17761046
[PubMed - indexed for MEDLINE]
8.

Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.

Quezada A, Baron-Papillon F, Coudeville L, Maggi L.

Rev Panam Salud Publica. 2008 May;23(5):303-12.

PMID:
18510790
[PubMed - indexed for MEDLINE]
9.

Economic evaluations of hepatitis B vaccination for developing countries.

Tu HA, Woerdenbag HJ, Kane S, Riewpaiboon A, van Hulst M, Postma MJ.

Expert Rev Vaccines. 2009 Jul;8(7):907-20. doi: 10.1586/erv.09.53. Review.

PMID:
19538116
[PubMed - indexed for MEDLINE]
10.

Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.

Navas E, Salleras L, Gisbert R, Dominguez A, Bruguera M, Rodríguez G, Galí N, Prat A.

Vaccine. 2005 Mar 18;23(17-18):2185-9.

PMID:
15755592
[PubMed - indexed for MEDLINE]
11.

Hepatitis A: the costs and benefits of the disease prevention by vaccine, Paraná, Brazil.

Zahdi MR, Maluf I Jr, Maluf EM.

Braz J Infect Dis. 2009 Aug;13(4):257-61.

PMID:
20231986
[PubMed - indexed for MEDLINE]
Free Article
12.

Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.

Pediatrics. 2007 Jan;119(1):e12-21.

PMID:
17200237
[PubMed - indexed for MEDLINE]
Free Article
13.

Cost-effectiveness of hepatitis A vaccination for adults in Belgium.

Luyten J, Van de Sande S, de Schrijver K, Van Damme P, Beutels P.

Vaccine. 2012 Sep 14;30(42):6070-80. doi: 10.1016/j.vaccine.2012.07.049. Epub 2012 Aug 2.

PMID:
22858555
[PubMed - indexed for MEDLINE]
14.

[Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].

Pan XJ, Feng YM, Zhuang GH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):862-6. Chinese.

PMID:
22967346
[PubMed - indexed for MEDLINE]
15.

Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.

Suijkerbuijk AW, Lugnér AK, van Pelt W, Wallinga J, Verhoef LP, de Melker HE, de Wit GA.

Vaccine. 2012 Jul 27;30(35):5199-205. doi: 10.1016/j.vaccine.2012.06.014. Epub 2012 Jun 18.

PMID:
22721900
[PubMed - indexed for MEDLINE]
16.

A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.

Zhuang GH, Pan XJ, Wang XL.

Vaccine. 2008 Aug 18;26(35):4608-16. doi: 10.1016/j.vaccine.2008.05.086. Epub 2008 Jun 13.

PMID:
18597903
[PubMed - indexed for MEDLINE]
17.

The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.

Jacobs RJ, Koff RS, Meyerhoff AS.

Am J Gastroenterol. 2002 Feb;97(2):427-34.

PMID:
11866283
[PubMed - indexed for MEDLINE]
18.

Cost-benefit analysis of hepatitis a vaccination in Thailand.

Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):118-27.

PMID:
12118439
[PubMed - indexed for MEDLINE]
19.

An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.

Das A.

Hepatology. 1999 Feb;29(2):548-52.

PMID:
9918934
[PubMed - indexed for MEDLINE]
20.

Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.

Jacobs RJ, Rosenthal P, Meyerhoff AS.

Vaccine. 2004 Mar 12;22(9-10):1241-8.

PMID:
15003653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk